AstraZeneca to highlight its commitment to blood cancers at 2017 ASH meeting

AstraZeneca along with Acerta Pharma, its haematology research and development centre of excellence, and MedImmune, its global biologics research and development arm, will highlight significant progress in

BiotherapeuticsThe field encompassing therapeutic materials produced using biological means, including recombinant DNA technology.
Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...